Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AbbVie Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
ABBV
New York
2836
www.abbvie.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AbbVie Inc.
Top Stock Reports for Eli Lilly, AbbVie & Gilead Sciences
- Dec 9th, 2024 8:15 pm
Two Data Analyses From Clinical Trials Show Epcoritamab (DuoBody® CD3xCD20) Induces Durable Complete Reponses As Monotherapy and Combination Treatment in Patients With Diffuse Large B-Cell Lymphoma
- Dec 9th, 2024 5:00 pm
AbbVie's Early Parkinson's Candidate Hits Primary Goal In Pivotal Late-Stage Study
- Dec 9th, 2024 4:16 pm
AbbVie Announces Positive Topline Results for the Phase 3 TEMPO-2 Trial Evaluating Tavapadon as a Monotherapy for Parkinson's Disease
- Dec 9th, 2024 1:00 pm
AbbVie Announces Emotional Impact Report on Mental Health of Underrepresented CLL Cancer Patients
- Dec 8th, 2024 8:00 pm
Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Therapy Shows High Response Rates in Clinical Trial of Patients With Relapsed or Refractory (R/R) Follicular Lymphoma (FL)
- Dec 8th, 2024 12:00 am
How To Put $100 In Your Retirement Fund Each Month With AbbVie Stock
- Dec 5th, 2024 2:00 pm
Merck's ADC Drug Gets FDA Breakthrough Therapy Tag in NSCLC
- Dec 4th, 2024 5:40 pm
Why Is AbbVie Inc. (ABBV) Among the Dividend Kings You Should Consider?
- Dec 4th, 2024 1:21 pm
From Cobenfy to Emraclidine: the muscarinic path to safer antipsychotics
- Dec 3rd, 2024 5:18 pm
Here is What to Know Beyond Why AbbVie Inc. (ABBV) is a Trending Stock
- Dec 3rd, 2024 2:00 pm
J&J Seeks FDA Approval for Tremfya for Psoriasis in Kids
- Dec 3rd, 2024 1:58 pm
3 High-Yield Dividend Growth Stocks to Buy in December and Hold for a Decade or Longer
- Dec 3rd, 2024 9:24 am
Why Dividend Aristocrats Like Walmart, ADP, and AbbVie Are Set to Outperform
- Dec 2nd, 2024 7:52 pm
3 Fantastic Dividend Stocks to Buy Sooner Rather Than Later
- Dec 1st, 2024 10:52 am
Why AbbVie Inc. (ABBV) Is One of the Most Profitable Pharmaceutical Stocks Right Now?
- Nov 30th, 2024 9:19 pm
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
- Nov 30th, 2024 10:41 am
Galderma Bets on Skin Drug to Turn Around Pharma Business
- Nov 29th, 2024 4:36 pm
Why Is AbbVie (ABBV) Down 10.2% Since Last Earnings Report?
- Nov 29th, 2024 4:31 pm
With 73% ownership in AbbVie Inc. (NYSE:ABBV), institutional investors have a lot riding on the business
- Nov 29th, 2024 11:00 am
Scroll